Tag: Glp 1 drugs

Effective July 1, 2025, CVS Caremark, one of the nation's largest pharmacy benefit managers (PBMs), removed Zepbound from its standard commercial formulary. This means that for many patients, the answer to 'Is Zepbound not available at CVS?' is tied directly to their insurance plan and requires exploring alternative pathways for coverage or access.

Following unprecedented demand, Eli Lilly resolved the widespread Zepbound shortage by investing billions in manufacturing expansions and strategic supply chain initiatives. This ultimately led the FDA to declare the tirzepatide supply issues resolved by December 2024.

On February 21, 2025, the U.S. Food and Drug Administration (FDA) officially declared the national shortage of Ozempic and Wegovy resolved, triggering a cascade of regulatory actions that directly impact what will happen to compounded semaglutide. This decision has led to a major crackdown on compounding pharmacies that have been producing unauthorized versions of the popular weight-loss and diabetes medication.

In recent reports, the city of Bowling Green, Kentucky, has earned the nickname "Ozempictown, USA," due to having the highest per capita usage of Ozempic and other GLP-1 medications in the country. This unusual moniker prompts the question, "What town in Kentucky is Ozempic?"—a query that reveals a common public misconception about the popular medication.

The U.S. Food and Drug Administration (FDA) first listed Zepbound on its drug shortage list in April 2024, citing immense demand that outpaced the manufacturer's production. The question, **Why is Zepbound out of stock everywhere?**, can be answered by examining the perfect storm of surging demand, manufacturing complexities, and regulatory changes affecting compounded alternatives.

According to celebrity reports and interviews, numerous famous figures have publicly revealed their experiences using Ozempic, or similar GLP-1 drugs, to manage their weight. This has sparked a widespread conversation about the off-label use of these medications, with celebrities offering candid testimonials about their journeys.

As of September 2025, Retatrutide is not yet available for prescription and therefore does not have an official list price. However, based on the cost of comparable GLP-1 medications, the anticipated cash price for a month's supply of Retatrutide is estimated to be over $1,000 without insurance.

According to official prescribing information, patients with type 2 diabetes taking Zepbound should be aware of a risk of temporary changes in vision. While many experience no eye-related issues, it's crucial for users to understand what are the side effects of Zepbound eyes, ranging from common, temporary visual disturbances to rare but serious conditions.

According to one study, an estimated 50-75% of users stop taking GLP-1 drugs like Ozempic within a year. So, why are people stopping Ozempic? The reasons are multifaceted, ranging from significant side effects to financial barriers and the risk of weight regain.